CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis)

A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis

NCT02932449 ·Status: COMPLETED

Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC)

NCT07104201 ·Status: RECRUITING ·Phase: EARLY_PHASE1

A Pilot Study of Fenofibrate and Ursodeoxycholic Acid in the Treatment of Newly Diagnosed Primary Biliary Cholangitis

NCT06591455 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis

NCT05751967 ·Status: RECRUITING ·Phase: PHASE3

Efficacy and Safety of Obeticholic Acid in the Treatment of Primary Biliary Cholangitis

NCT05450887 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis

NCT05104853 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of the Efficacy and Safety of CF102 in the Treatment of Non-Alcoholic Fatty Liver Disease

NCT02927314 ·Status: COMPLETED ·Phase: PHASE2

A Phase II Clinical Trial of Chiglitazar for NASH

NCT05193916 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Biliary Cholangitis Without Cirrhosis

NCT02943447 ·Status: TERMINATED ·Phase: PHASE2

Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients

NCT05292872 ·Status: COMPLETED

Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Sclerosing Cholangitis Without Cirrhosis

NCT02943460 ·Status: COMPLETED ·Phase: PHASE2

A Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients

NCT05293938 ·Status: WITHDRAWN

Fenofibrate in Primary Biliary Cholangitis: a Real World Study

NCT06755151 ·Status: RECRUITING ·Phase: PHASE3

Mitomycin C Therapy for Patients With Primary Sclerosing Cholangitis

NCT01688024 ·Status: UNKNOWN ·Phase: PHASE2

Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World Study

NCT06755541 ·Status: RECRUITING ·Phase: PHASE3

Pilot Study of Ursodesoxycholic Acid in Non-Alcoholic Steatohepatitis

NCT00470171 ·Status: COMPLETED ·Phase: PHASE2

Fenofibrate in Patients With Primary Biliary Cholangitis (PBC)

NCT06365424 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness

NCT05014672 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Fenofibrate Combined With UDCA in PBC Patients With an Incomplete Biochemical Response to UDCA

NCT02965911 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of CS0159 in Subjects With NASH

NCT05591079 ·Status: COMPLETED ·Phase: PHASE2

6-week Safety and PD Study in Adults With NAFLD

NCT03256526 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of Pruritus

NCT01899703 ·Status: COMPLETED ·Phase: PHASE2

A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of Tropifexor (LJN452) in PBC Patients

NCT02516605 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC

NCT06699121 ·Status: RECRUITING ·Phase: PHASE2

Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC)

NCT02128958 ·Status: COMPLETED ·Phase: PHASE2